Personalized Medicine

Papers
(The TQCC of Personalized Medicine is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)
ArticleCitations
The Integration of Personalized Medicine Into Health Systems: Progress and a Path Forward59
Pharmacogenomics education in China and the United States: advancing personalized medicine29
Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis20
An evidence gap map of the personalized medicine in bladder cancer17
Microsatellite Instability Testing in Colorectal Patients with Lynch Syndrome: Lessons Learned from a Case Report and How to Avoid Such Pitfalls16
A scoping review of the cost-effectiveness of precision treatment in chronic lymphocytic leukemia14
Perceived understanding and psychosocial outcomes: employees’ responses to learning results of workplace genetic testing14
miR-559 rs58450758 polymorphism is associated with colorectal cancer risk and prognosis in Chinese Han population13
The Pharmacogenetics of Mycophenolate Mofetil in Tunisian Renal Transplant Patients10
Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension9
Developing the Workplace Learning Social System: considerations for genomics implementation and workforce preparedness9
The rs2275738 variant of the adiponectin receptor 1 gene is associated with biopsy-proven nonalcoholic fatty liver disease9
Precision acute medical care through “-omic” analyses: a scoping review8
The interplay between pharmacogenetics, concomitant drugs and blood levels of amitriptyline and its main metabolites8
Association between IL-6, miRNA-146a, MALAT1 genetic polymorphisms and risk of rheumatoid arthritis8
Mutational signatures in appendiceal adenocarcinomas: potential for future personalization in hyperthermic intraperitoneal chemotherapy?8
Prevalence of Protective Haplotypes of the SLCO1B1 Gene for Statin Transport in Mexican Populations8
Refining Personalized Diagnosis, Treatment and Exploitation of Hypothyroidism Related to Solid Nonthyroid Cancer7
Personalized approach in arrhythmology by genetic-based data: a case report7
The effect of RNLS gene polymorphisms on preeclampsia susceptibility: a meta-analysis study6
Omics Technologies in Personalized Combination Therapy for Cardiovascular Diseases: Challenges and Opportunities6
Val66Met polymorphism in the BDNF gene and antidepressant response in depression: an updated meta-analysis6
How can we address the uncertainties regarding the potential clinical utility of polygenic score-based tests?6
Knowledge, attitudes and practice regarding pharmacovigilance and adverse drug reaction reporting among physicians and pharmacists in Egypt: a step toward personalized medicine implementation6
miR-938 rs2505901 T>C Polymorphism Increases Hirschsprung Disease Risk: A Case–Control Study of Chinese Children6
Enhancing Parkinson’s disease prediction using meta-heuristic optimized machine learning models6
Role of precision nutrition in improving military performance5
Cost–effectiveness and budget impact analysis of screening strategies for maturity-onset diabetes of the young in three European countries5
Regional disparities in access to gene therapies in the European Union, the United States, Japan, and China5
Welcome to the 19th Volume of Personalized Medicine5
Identification of novel variants of XPA and POLH/XPV genes in xeroderma pigmentosum patients in Vietnam5
Gene expression profiling of peripheral blood in patients with steroid-induced osteonecrosis of the femoral head5
The Frequency of Major CYP2C19 Genetic Polymorphisms in Women of Asian, Native Hawaiian and Pacific Islander Subgroups5
Looking Back Over 2023 and Welcome to the 21 st Issue of Personalized Medicine5
A Personalized Approach to Pancreatic Ductal Adenocarcinoma and its Application in Surgical Practice5
Precision medicine activities and opportunities for shaping maternal and neonatal health in Qatar5
Cost–effectiveness of extended DPYD testing before fluoropyrimidine chemotherapy in metastatic breast cancer in the UK4
HEcoPerMed, Personalized Medicine from a Health Economic Perspective: Lessons Learned and Potential Opportunities Ahead4
Genomics and the early diagnosis of lung cancer4
Identification of Dpyd Variants and Estimation of Uracil and Dihydrouracil in A Healthy Indian Population4
Cloud-based Digital Healthcare Development for Precision Medical Hospital Information System4
Exploring the usefulness of plasma level determination and pharmacogenetics for patients treated with clozapine4
Association of miR-21 gene polymorphisms with cognitive function in patients with systemic lupus erythematosus4
Development of Competency-based Online Genomic Medicine Training (COGENT)4
Whole-exome sequencing reveals novel variants associated with abnormal uterine bleeding caused by copper intrauterine device4
Diagnostic Utility of the 23-gene Expression Profile Test for an Atypical Intradermal Melanocytic Proliferation4
0.19618391990662